Client: US-headquartered institutional asset manager with over$250 billion in AUM. The client manages sustainability funds that invest in the Pharmaceuticals and Life Sciences sector
Our client observed multiple news reports that reported significant lapses in compliance with environmental and social requirements across Asia-based manufacturers of API’sand intermediates. The client had significant holdings in Pharmaceuticals and Life Sciences stocks that sourced from these Asia-based manufacturers. The client wanted a comprehensive assessment of ESG compliance across these companies to gauge their exposure to ESG risks.
SG Analytics deployed a three-pronged approach comprising of desk research, primary research, and field research to gather information on ESG compliance across suppliers.
I love SG Analytics energy and commitment. I would like to thank them for all the hard work on this project. They have done a great job and we really appreciated their flexibility – Director Research